My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 311

    1.

    Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes.

    Larsen JR, Sjoholm H, Hanssen KF, Sandvik L, Berg TJ, Dahl-Jorgensen K.

    Diabetes Care. 2003 Aug;26(8):2400-4.PMID: 12882869 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes.

    Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jørgensen K.

    Diabetes Care. 2004 Apr;27(4):963-6.PMID: 15047656 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    4.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    7.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hemoglobin Glycosylation Index is not related with blood glucose.

    Merino-Torres JF, Fajardo-Montañana C, Ferrer-García JC, Piñón-Sellés F.

    J Diabetes Complications. 2003 Sep-Oct;17(5):249-53.PMID: 12954152 [PubMed - indexed for MEDLINE]Related articles

    9.

    Subclinical nerve dysfunction in children and adolescents with IDDM.

    Hyllienmark L, Brismar T, Ludvigsson J.

    Diabetologia. 1995 Jun;38(6):685-92.PMID: 7672490 [PubMed - indexed for MEDLINE]Related articles

    10.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    11.

    Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden.

    Svensson M, Eriksson JW, Dahlquist G.

    Diabetes Care. 2004 Apr;27(4):955-62.PMID: 15047655 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

    Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group.

    Diabetes Metab. 2003 Dec;29(6):587-94.PMID: 14707887 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ethnic differences in glycaemic control in adult Type 2 diabetic patients in primary care: a 3-year follow-up study.

    Ng TP, Goh LG, Tan Y, Tan E, Leong H, Tay EG, Thai AC.

    Diabet Med. 2005 Nov;22(11):1598-604.PMID: 16241927 [PubMed - indexed for MEDLINE]Related articles

    15.

    Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function.

    Plater ME, Ford I, Dent MT, Preston FE, Ward JD.

    Diabetologia. 1996 Mar;39(3):336-43.PMID: 8721780 [PubMed - indexed for MEDLINE]Related articles

    16.

    The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.

    Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood.

    J Diabetes Complications. 2004 May-Jun;18(3):160-4.PMID: 15145327 [PubMed - indexed for MEDLINE]Related articles

    17.

    Somatic and autonomic nerve function during the first year after diagnosis of type 1 (insulin-dependent) diabetes.

    Ziegler D, Cicmir I, Mayer P, Wiefels K, Gries FA.

    Diabetes Res. 1988 Mar;7(3):123-7.PMID: 3046819 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

    Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK.

    Diabetes Care. 2000 Oct;23(10):1478-85.PMID: 11023140 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

    Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

    Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comorbidity and glycemic control in patients with type 2 diabetes.

    El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS.

    Arch Intern Med. 2001 May 28;161(10):1295-300.PMID: 11371257 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity